{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:30:53Z","timestamp":1772166653346,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12DK111028"],"award-info":[{"award-number":["K12DK111028"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      (ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      ) may occur as outbreaks due to common-source exposures. Yet, it is currently unknown if they cluster geographically as would be expected as part of an outbreak.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We collected electronic health record data on all patients living in San Francisco with culture-documented community-onset\n                      <jats:italic>E. coli<\/jats:italic>\n                      bacteriuria in a safety-net public healthcare system from January 2014 to March 2020 (diagnosed\u2009&lt;\u200948\u00a0h after hospital admission or in outpatient clinical settings without a hospitalization in the past 90 days). We assessed the presence of spatial clusters of (1) ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      bacteriuria episodes, and (2) individuals with any ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      bacteriuria episode, with Global and Local Moran\u2019s I. We evaluated differences in prevalence of bacteriuria recurrence by ESBL-production by Poisson regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 4,304 unique individuals, we identified spatial clusters of ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      bacteriuria episodes (n\u2009=\u2009461) compared to non-ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      bacteriuria episodes (n\u2009=\u20095477; Global Moran\u2019s p\u2009&lt;\u20090.001). Spatial clusters of individuals with any bacteriuria caused by ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      were not identified (p\u2009=\u20090.43). Bacteriuria recurrence was more likely to occur with ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      (odds ratio [OR] 2.78, 95% confidence interval [95% CI] 2.10, 3.66, p\u2009&lt;\u20090.001), particularly after an initial ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      bacteriuria episode (OR 2.27, 95% CI 1.82, 2.83, p\u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      We found spatial clusters of ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      bacteriuria episodes. However, this was partly explained by clustering within individuals more than between individuals, as having an ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      bacteriuria was associated with recurrence with ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      . These findings may help better tailor clinical treatment of patients with recurrent urinary tract infections after an initial episode caused by ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-023-01320-1","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T20:02:33Z","timestamp":1697745753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatial clusters of extended-spectrum beta-lactamase-producing Escherichia coli causing community-onset bacteriuria due to repeat infections: cluster analysis from a large urban medical center, San Francisco, 2014\u20132020"],"prefix":"10.1186","volume":"12","author":[{"given":"Eva","family":"Raphael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pushkar P.","family":"Inamdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheyenne","family":"Belmont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma","family":"Shariff-Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry F.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"1320_CR1","volume-title":"Antibiotic resistance threats in the United States, 2019 Atlanta","author":"CDC","year":"2019","unstructured":"CDC. Antibiotic resistance threats in the United States, 2019 Atlanta. GA: U.S. Department of Health and Human Services, CDC; 2019."},{"issue":"1","key":"1320_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2047-2994-3-9","volume":"3","author":"SZ Kassakian","year":"2014","unstructured":"Kassakian SZ, Mermel LA. Changing epidemiology of Infections due to extended spectrum beta-lactamase producing bacteria. Antimicrob Resist Infect Control. 2014;3(1):9.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1320_CR3","doi-asserted-by":"crossref","unstructured":"van Driel AA, Notermans DW, Meima A et al. Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period. Eur J Clin Microbiol Infect Dis 2019.","DOI":"10.1007\/s10096-019-03655-3"},{"issue":"3","key":"1320_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JD Pitout","year":"2008","unstructured":"Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159\u201366.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"1320_CR5","doi-asserted-by":"publisher","first-page":"e770","DOI":"10.1016\/j.ijid.2010.02.2264","volume":"14","author":"PH Bours","year":"2010","unstructured":"Bours PH, Polak R, Hoepelman AI, Delgado E, Jarquin A, Matute AJ. Increasing resistance in community-acquired urinary tract Infections in Latin America, five years after the implementation of national therapeutic guidelines. Int J Infect Dis. 2010;14(9):e770\u2013774.","journal-title":"Int J Infect Dis"},{"key":"1320_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jgar.2018.03.004","volume":"14","author":"FA Lagunas-Rangel","year":"2018","unstructured":"Lagunas-Rangel FA. Antimicrobial susceptibility profiles of bacteria causing urinary tract Infections in Mexico: single-centre experience with 10 years of results. J Glob Antimicrob Resist. 2018;14:90\u20134.","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"1320_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3947\/ic.2017.49.3.184","volume":"49","author":"JJ Park","year":"2017","unstructured":"Park JJ, Seo YB, Lee J. Antimicrobial susceptibilities of Enterobacteriaceae in Community-acquired urinary tract Infections during a 5-year period: a single hospital study in Korea. Infect Chemother. 2017;49(3):184\u201393.","journal-title":"Infect Chemother"},{"issue":"5","key":"1320_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/cid\/cis942","volume":"56","author":"Y Doi","year":"2013","unstructured":"Doi Y, Park YS, Rivera JI, et al. Community-associated extended-spectrum beta-lactamase-producing Escherichia coli Infection in the United States. Clin Infect Dis. 2013;56(5):641\u20138.","journal-title":"Clin Infect Dis"},{"key":"1320_CR9","doi-asserted-by":"publisher","first-page":"104452","DOI":"10.1016\/j.meegid.2020.104452","volume":"85","author":"AP de Souza da-Silva","year":"2020","unstructured":"de Souza da-Silva AP, de Sousa VS, de Ara\u00fajo Longo LG, et al. Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract Infections in Rio De Janeiro: impact of genotypes ST69 and ST131. Infect Genet Evol. 2020;85:104452.","journal-title":"Infect Genet Evol"},{"key":"1320_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s40471-019-00206-4","volume":"6","author":"CR Butcher","year":"2019","unstructured":"Butcher CR, Rubin J, Mussio K, Riley LW. Risk factors Associated with Community-acquired urinary tract Infections caused by extended-spectrum \u2264-Lactamase-producing Escherichia coli: a systematic review. Curr Epidemiol Rep. 2019;6:300\u20139.","journal-title":"Curr Epidemiol Rep"},{"issue":"7","key":"1320_CR11","doi-asserted-by":"publisher","first-page":"e69581","DOI":"10.1371\/journal.pone.0069581","volume":"8","author":"A Soraas","year":"2013","unstructured":"Soraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. Risk factors for community-acquired urinary tract Infections caused by ESBL-producing enterobacteriaceae\u2013a case-control study in a low prevalence country. PLoS ONE. 2013;8(7):e69581.","journal-title":"PLoS ONE"},{"issue":"6","key":"1320_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.tmaid.2016.11.012","volume":"14","author":"JP Strysko","year":"2016","unstructured":"Strysko JP, Mony V, Cleveland J, Siddiqui H, Homel P, Gagliardo C. International travel is a risk factor for extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae acquisition in children: a case-case-control study in an urban U.S. hospital. Travel Med Infect Dis. 2016;14(6):568\u201371.","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"1320_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1017\/S0950268817002680","volume":"146","author":"UV Ukah","year":"2018","unstructured":"Ukah UV, Glass M, Avery B, et al. Risk factors for acquisition of multidrug-resistant Escherichia coli and development of community-acquired urinary tract Infections. Epidemiol Infect. 2018;146(1):46\u201357.","journal-title":"Epidemiol Infect"},{"key":"1320_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fmicb.2013.00029","volume":"4","author":"L Nordstrom","year":"2013","unstructured":"Nordstrom L, Liu CM, Price LB. Foodborne urinary tract Infections: a new paradigm for antimicrobial-resistant foodborne Illness. Front Microbiol. 2013;4:29.","journal-title":"Front Microbiol"},{"key":"1320_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-food-032519-051618","volume":"11","author":"LW Riley","year":"2020","unstructured":"Riley LW. Extraintestinal Foodborne pathogens. Annu Rev Food Sci Technol. 2020;11:275\u201394.","journal-title":"Annu Rev Food Sci Technol"},{"key":"1320_CR16","volume-title":"Principles of Epidemiology in Public Health Practice: an introduction to Applied Epidemiology and Biostatistics","author":"CDC","year":"2012","unstructured":"CDC. Principles of Epidemiology in Public Health Practice: an introduction to Applied Epidemiology and Biostatistics. 3rd ed. Atlanta, GA: U.S. Department of Health and Human Services; 2012.","edition":"3"},{"issue":"3","key":"1320_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/antibiotics2030328","volume":"2","author":"S Galvin","year":"2013","unstructured":"Galvin S, Bergin N, Hennessy R, et al. Exploratory spatial mapping of the occurrence of Antimicrobial Resistance in E. Coli in the community. Antibiot (Basel). 2013;2(3):328\u201338.","journal-title":"Antibiot (Basel)"},{"key":"1320_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1476-072X-10-17","volume":"10","author":"CR Kiffer","year":"2011","unstructured":"Kiffer CR, Camargo EC, Shimakura SE, et al. A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: the emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, Brasil. Int J Health Geogr. 2011;10:17.","journal-title":"Int J Health Geogr"},{"issue":"5","key":"1320_CR19","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/jac\/dkab020","volume":"76","author":"D Nobrega","year":"2021","unstructured":"Nobrega D, Peirano G, Lynch T, Finn TJ, Devinney R, Pitout JDD. Spatial distribution of Escherichia coli ST131 C subclades in a centralized Canadian urban region. J Antimicrob Chemother. 2021;76(5):1135\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"1320_CR20","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3201\/eid2708.204235","volume":"27","author":"V Sarda","year":"2021","unstructured":"Sarda V, Trick WE, Zhang H, Schwartz DN. Spatial, ecologic, and clinical epidemiology of Community-Onset, Ceftriaxone-Resistant Enterobacteriaceae, Cook County, Illinois, USA. Emerg Infect Dis. 2021;27(8):2127\u201334.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"1320_CR21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00192-014-2569-5","volume":"26","author":"A Aydin","year":"2015","unstructured":"Aydin A, Ahmed K, Zaman I, Khan MS, Dasgupta P. Recurrent urinary tract Infections in women. Int Urogynecol J. 2015;26(6):795\u2013804.","journal-title":"Int Urogynecol J"},{"key":"1320_CR22","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing Wayne, PA2016."},{"issue":"2","key":"1320_CR23","doi-asserted-by":"publisher","first-page":"e008256","DOI":"10.1161\/CIRCOUTCOMES.121.008256","volume":"15","author":"EF Liu","year":"2022","unstructured":"Liu EF, Rubinsky AD, Pacca L, et al. Examining Neighborhood Socioeconomic Status as a mediator of Racial\/Ethnic disparities in Hypertension Control Across Two San Francisco Health Systems. Circ Cardiovasc Qual Outcomes. 2022;15(2):e008256.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"1320_CR24","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1128\/JCM.03361-13","volume":"52","author":"A Poulou","year":"2014","unstructured":"Poulou A, Grivakou E, Vrioni G, et al. Modified CLSI extended-spectrum beta-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various beta-lactamases. J Clin Microbiol. 2014;52(5):1483\u20139.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1320_CR25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57(1):289\u2013300.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"1320_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.0016-7363.2006.00682.x","volume":"38","author":"M Caldas de Castro","year":"2006","unstructured":"Caldas de Castro M, Singer BH. Controlling the false Discovery rate: a New Application to Account for multiple and dependent test in Local Statistics of Spatial Association. Geographical Anal. 2006;38:180\u2013208.","journal-title":"Geographical Anal"},{"issue":"2","key":"1320_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40121-019-0237-2","volume":"8","author":"LK Logan","year":"2019","unstructured":"Logan LK, Medernach RL, Domitrovic TN, et al. The clinical and molecular epidemiology of CTX-M-9 Group Producing Enterobacteriaceae Infections in Children. Infect Dis Ther. 2019;8(2):243\u201354.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"1320_CR28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1186\/s12879-020-05267-1","volume":"20","author":"D Arias Ramos","year":"2020","unstructured":"Arias Ramos D, Hoyos Pulgarin JA, Moreno Gomez GA, et al. Geographic mapping of Enterobacteriaceae with extended-spectrum beta-lactamase (ESBL) phenotype in Pereira, Colombia. BMC Infect Dis. 2020;20(1):540.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1320_CR29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12889-019-6804-3","volume":"19","author":"F Terahara","year":"2019","unstructured":"Terahara F, Nishiura H. Fluoroquinolone consumption and Escherichia coli resistance in Japan: an ecological study. BMC Public Health. 2019;19(1):426.","journal-title":"BMC Public Health"},{"issue":"4","key":"1320_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1473-3099(18)30676-5","volume":"19","author":"M Low","year":"2019","unstructured":"Low M, Neuberger A, Hooton TM, et al. Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study. Lancet Infect Dis. 2019;19(4):419\u201328.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"1320_CR31","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jiac.2019.02.006","volume":"25","author":"ST Ahn","year":"2019","unstructured":"Ahn ST, Kim SW, Kim JW, Park HS, Moon DG, Oh MM. Does urinary tract Infection caused by extended-spectrum beta-lactamase-producing Escherichia coli show same antibiotic resistance when it recurs? J Infect Chemother. 2019;25(7):498\u2013502.","journal-title":"J Infect Chemother"},{"issue":"1","key":"1320_CR32","doi-asserted-by":"publisher","first-page":"10048","DOI":"10.1038\/s41598-022-14177-y","volume":"12","author":"A Lindblom","year":"2022","unstructured":"Lindblom A, Kiszakiewicz C, Kristiansson E, et al. The impact of the ST131 clone on recurrent ESBL-producing E. Coli urinary tract Infection: a prospective comparative study. Sci Rep. 2022;12(1):10048.","journal-title":"Sci Rep"},{"key":"1320_CR33","volume-title":"Racial Segregation in the San Francisco Bay Area","author":"S Menendian","year":"2018","unstructured":"Menendian S, Gambhir S. Racial Segregation in the San Francisco Bay Area. Berkeley: University of California; 2018."},{"issue":"suppl1","key":"1320_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/jtm\/taw102","volume":"24","author":"Y Doi","year":"2017","unstructured":"Doi Y, Iovleva A, Bonomo RA. The ecology of extended-spectrum beta-lactamases (ESBLs) in the developed world. J Travel Med. 2017;24(suppl1):44\u2013S51.","journal-title":"J Travel Med"},{"issue":"4","key":"1320_CR35","doi-asserted-by":"publisher","first-page":"e00470","DOI":"10.1128\/mBio.00470-18","volume":"9","author":"CM Liu","year":"2018","unstructured":"Liu CM, Stegger M, Aziz M, et al. Escherichia coli ST131-H22 as a Foodborne Uropathogen. mBio. 2018;9(4):e00470\u201300418.","journal-title":"mBio"},{"key":"1320_CR36","unstructured":"USCB. S0701 Geographic mobility by selected characteristics in the United States. In: ACS; 2021."},{"issue":"5","key":"1320_CR37","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103\u2013120.","journal-title":"Clin Infect Dis"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-023-01320-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-023-01320-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-023-01320-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T01:47:01Z","timestamp":1730339221000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-023-01320-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1320"],"URL":"https:\/\/doi.org\/10.1186\/s13756-023-01320-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2949551\/v1","asserted-by":"object"}]},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"assertion":[{"value":"17 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by institutional review boards from UCSF and SFGH (IRB number 19-27233).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}